0001478242-22-000045.txt : 20220314 0001478242-22-000045.hdr.sgml : 20220314 20220314170317 ACCESSION NUMBER: 0001478242-22-000045 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20220310 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220314 DATE AS OF CHANGE: 20220314 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IQVIA HOLDINGS INC. CENTRAL INDEX KEY: 0001478242 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 271341991 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35907 FILM NUMBER: 22737419 BUSINESS ADDRESS: STREET 1: 4820 EMPEROR BLVD. CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-998-2000 MAIL ADDRESS: STREET 1: 4820 EMPEROR BLVD. CITY: DURHAM STATE: NC ZIP: 27703 FORMER COMPANY: FORMER CONFORMED NAME: Quintiles IMS Holdings, Inc. DATE OF NAME CHANGE: 20161003 FORMER COMPANY: FORMER CONFORMED NAME: Quintiles Transnational Holdings Inc. DATE OF NAME CHANGE: 20091208 8-K 1 iqv-20220310.htm 8-K iqv-20220310
0001478242FALSE00014782422022-03-102022-03-10

UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549
______________
FORM 8-K
______________
 
CURRENT REPORT

 Pursuant to Section 13 or 15(d) of the
 Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): March 14, 2022 (March 10, 2022)
______________
IQVIA HOLDINGS INC.
(Exact name of registrant as specified in its charter)
______________
Delaware001-3590727-1341991
(State or other jurisdiction
of incorporation)		(Commission
File Number)		(IRS Employer
Identification No.)

4820 Emperor Blvd.
Durham, North Carolina 27703
(Address of principal executive offices)
 
Registrant’s telephone number, including area code: (919) 998-2000
 
Not Applicable
 (Former name or former address, if changed since last report.)
 ______________
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class Trading Symbol Name of Each Exchange on which Registered
Common Stock, par value $0.01 per share “IQV” New York Stock Exchange LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐



Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 14, 2022, IQVIA Holdings Inc. (the “Company”) announced the appointment of Costa Panagos as President of its Research & Development Solutions (“R&DS”) business unit, effective April 1, 2022. Mr. Panagos has more than 25 years of industry experience serving life sciences customers and managing contract research organizations. Mr. Panagos joined the company in 1999 and has held numerous sales, operational and executive leadership positions across the Company. Mr. Panagos currently serves as President, Research & Development Operations, where he is responsible for the global delivery of all clinical trials, including traditional full-service trials, decentralized clinical trials and flexible staffing arrangements. Prior to his current role, Mr. Panagos served as chief executive officer of Q2 Solutions, the Company’s global clinical trial laboratory business. Before joining the Company, Mr. Panagos held various roles in the pharmaceutical division of Bayer. Mr. Panagos earned a bachelor’s degree in Biology from Brown University and an MBA from the University of Chicago Booth School of Business.

On this same date, the Company announced that Richard Staub III, President, R&DS, will retire from his current role effective April 1, 2022 but will remain with the Company as a senior advisor to the Chief Executive Officer (the “CEO”) to play an important role in business development efforts, serve on customer governance boards, and ensure a smooth transition. In Mr. Staub’s role as Senior Advisor to the CEO, he will receive compensation commensurate with this new role.


Item 9.01    Financial Statements and Exhibits.

(d) Exhibits
Exhibit No.Description
99.1
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)


SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:  March 14, 2022
 
IQVIA HOLDINGS INC.  
    
 By: /s/ Eric M. Sherbet
   Eric M. Sherbet
Executive Vice President, General Counsel and Secretary


 EX-99.1 2 exhibit991.htm EX-99.1 Document
Exhibit 99.1
image.jpg
NEWS


Contact:    Nick Childs, IQVIA Investor Relations (nick.childs@iqvia.com)
+1.973.316.3828

Tor Constantino, IQVIA Media Relations (tor.constantino@iqvia.com)
+1.484.567.6732    


IQVIA Appoints Costa Panagos President of Research & Development Solutions (R&DS)

RESEARCH TRIANGLE PARK, N.C. – March 14, 2022 – IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and contract services to the life sciences industry, today announced the appointment of Costa Panagos, to serve as president of its Research & Development Solutions (R&DS) business unit.  He is succeeding Richard Staub III, who is retiring after a successful career spanning more than three decades.  Mr. Staub will remain with the company as a senior advisor to the CEO and continue supporting business development and client management activities.

Mr. Panagos has more than 25 years of industry experience serving life sciences customers and managing contract research (CRO) organizations. He joined the company in 1999 and has held numerous sales, operational and executive leadership positions across the company. Panagos currently serves as president, Research & Development Operations where he is responsible for the global delivery of all clinical trials, including traditional full-service trials, decentralized clinical trials and flexible staffing arrangements.

Prior to his current role, Panagos served as CEO of Q2 Solutions, IQVIA’s global clinical trial laboratory business. Before IQVIA, Panagos held various roles in the pharmaceutical division of Bayer. He earned a bachelor’s degree in Biology from Brown University and an MBA from the University of Chicago Booth School of Business.

“Costa is an experienced executive with a strong operational focus and is widely respected within IQVIA and across the industry. This has been the succession plan for a long time, and it will be a quick and seamless transition,” said Ari Bousbib, Chairman and CEO of IQVIA. “I would like to thank Richard for his leadership and extraordinary contributions to our business during his tenure.  Richard will continue to play an important role in business development efforts, serve on customer governance boards, and ensure a smooth transition,” Bousbib added.

Mr. Panagos’ appointment will be effective from April 1, 2022.


About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and



extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 79,000 employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.

# # #



EX-101.SCH 3 iqv-20220310.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 iqv-20220310_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Address, Street Entity Address, Address Line One Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Written Communications Written Communications Local Phone Number Local Phone Number Soliciting Material Soliciting Material Entity Address, State Entity Address, State or Province City Area Code City Area Code Document Type Document Type Document Period End Date Document Period End Date Cover [Abstract] Entity Address, City Entity Address, City or Town Entity Central Index Key Entity Central Index Key Pre-commencement Tender Offer Pre-commencement Tender Offer (Commission File Number) Entity File Number Amendment Flag Amendment Flag (IRS Employer Identification No.) Entity Tax Identification Number Entity Emerging Growth Company Entity Emerging Growth Company Current Fiscal Year End Date Current Fiscal Year End Date (State or other jurisdiction of incorporation) Entity Incorporation, State or Country Code EX-101.PRE 5 iqv-20220310_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 6 image.jpg begin 644 image.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.0.1
Cover
Mar. 10, 2022
Cover [Abstract]  
Document Type 8-K
Document Period End Date Mar. 10, 2022
Entity Registrant Name IQVIA HOLDINGS INC.
(State or other jurisdiction of incorporation) DE
(Commission File Number) 001-35907
(IRS Employer Identification No.) 27-1341991
Entity Address, Street 4820 Emperor Blvd.
Entity Address, City Durham
Entity Address, State NC
Entity Address, Postal Zip Code 27703
City Area Code 919
Local Phone Number 998-2000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0001478242
Amendment Flag false
Current Fiscal Year End Date
XML 8 iqv-20220310_htm.xml IDEA: XBRL DOCUMENT 0001478242 2022-03-10 2022-03-10 0001478242 false 8-K 2022-03-10 IQVIA HOLDINGS INC. DE 001-35907 27-1341991 4820 Emperor Blvd. Durham NC 27703 919 998-2000 false false false false false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.0.1 html 1 122 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Sheet http://www.iqvia.com/role/Cover Cover Cover 1 false false All Reports Book All Reports iqv-20220310.htm exhibit991.htm iqv-20220310.xsd iqv-20220310_lab.xml iqv-20220310_pre.xml http://xbrl.sec.gov/dei/2021q4 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "iqv-20220310.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "iqv-20220310.htm" ] }, "labelLink": { "local": [ "iqv-20220310_lab.xml" ] }, "presentationLink": { "local": [ "iqv-20220310_pre.xml" ] }, "schema": { "local": [ "iqv-20220310.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 21, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 122, "memberCustom": 0, "memberStandard": 0, "nsprefix": "iqv", "nsuri": "http://www.iqvia.com/20220310", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iqv-20220310.htm", "contextRef": "i76555f04a3e242f2ac0ee85f170bf011_D20220310-20220310", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://www.iqvia.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "iqv-20220310.htm", "contextRef": "i76555f04a3e242f2ac0ee85f170bf011_D20220310-20220310", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.iqvia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.iqvia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.iqvia.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.iqvia.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.iqvia.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Street" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.iqvia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "verboseLabel": "Entity Address, City" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.iqvia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.iqvia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.iqvia.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.iqvia.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.iqvia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "(Commission File Number)" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.iqvia.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "(State or other jurisdiction of incorporation)" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.iqvia.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.iqvia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "(IRS Employer Identification No.)" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.iqvia.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.iqvia.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.iqvia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.iqvia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.iqvia.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.iqvia.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r4": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001478242-22-000045-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001478242-22-000045-xbrl.zip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end